Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
10/2001
10/11/2001WO2001074827A1 Phosphoramidate prodrugs
10/11/2001US20010029296 Minimization of blooming in high-density arrays by using reactive wash reagents
10/11/2001US20010029028 Method and apparatus for combinatorial chemistry
10/11/2001CA2397203A1 Phosphoramidate prodrugs
10/10/2001EP1141409A1 A system and methods for nucleic acid sequencing of single molecules by polymerase synthesis
10/10/2001EP1141394A1 Nucleic acid sequencing method
10/10/2001EP1141137A1 Water-soluble rhodamine dyes and conjugates thereof
10/10/2001EP1140965A1 Protonated/acidified nucleic acids and methods of use
10/10/2001EP1140957A1 Selective solvent extraction for the purification of protected nucleosides
10/10/2001EP1140937A2 Antiviral nucleoside analogues
10/10/2001EP1140933A2 Process for preparing n6-substituted deaza-adenosine derivatives
10/10/2001EP1140116A1 Use of adenosine agonists in cancer therapy
10/10/2001EP1140104A1 Methods for increasing cytidine levels in vivo and treating cytidine-dependent human diseases
10/10/2001EP1100512A4 Preparation of thioarabinofuranosyl compounds and use thereof
10/10/2001CN1317008A Novel antibacterial compounds
10/09/2001US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers
10/09/2001US6300486 Condensing a nucleoside having one hydroxyl end bearing a h-phosphonate group and the other protected with polymer-bound nucleoside having free hydroxyl end in solvent which swells polymer, deprotecting, repeating, oxidation
10/09/2001US6300074 Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
10/04/2001WO2001073110A1 Stabilization of highly sensitive nucleic acid stains in aqueous solutions
10/04/2001WO2001073095A2 Preparation of deoxynucleosides
10/04/2001WO2001072764A1 N?8- and c8¿-linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotide hybridization
10/04/2001WO2001072294A2 Method of treating hepatitis delta viral infection
10/04/2001WO2001072288A2 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
10/04/2001WO2001016369A3 Uv excitable fluorescent energy transfer dyes
10/04/2001US20010027251 Mimic or modulate activity of wild-type nucleic acids thereby affecting protein production or activity
10/04/2001US20010027187 Such as hydroxyethylated bis(trimethoxysilylpropyl)amine as well as modified polyamines for use as silylating agents in surface treatment of silica and in formation of nucleic acid arrays
10/04/2001US20010027185 Methods and compositions for treating inflammatory response
10/04/2001US20010026918 Reducing background signals; accuracy
10/04/2001EP1138775A2 Method of preparing a guanosine-group compound and an intermediate thereof
10/04/2001EP1138689A1 N8- and C8-linked purine bases as universal nucleosides used for oligonucleotide hybridization
10/04/2001EP1138688A1 N8- and C8- linked purine bases as universal nucleosides used for oligonucleotide hybridization
10/04/2001EP1137812A1 Dna-protein fusions and uses thereof
10/04/2001EP0708781B1 A 3 adenosine receptor agonists
10/04/2001EP0674646B1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/2001CA2405502A1 Method of treating hepatitis delta viral infection
10/03/2001CN1315862A Medicinal compositions for treating eye diseases
10/02/2001US6297223 Administering 5-substituted- or 5,6-dihydro-5-substituted-uracil derivative or a prodrug thereof; in conjunction with 5-fluorouracil or pro-drug thereof.
10/02/2001US6297222 Treating or preventing radiation, mutagen and sunlight-induced biological damage, and methods for improving wound healing and tissue repair
09/2001
09/27/2001WO2001004134A3 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them
09/27/2001US20010025043 New pharmaceutical active compounds
09/27/2001US20010025032 Administering mixture of nucleosides; anticancer agent
09/26/2001EP1135401A1 Glyceryl nucleotides, method for the production thereof and their use
09/26/2001EP0923597B1 Substituted propargylethoxyamido nucleosides
09/26/2001EP0707591B1 Methylphosphonic acid ester, process for preparing the same and its use
09/26/2001CN1314913A Directed combinatorial compound library and high throughput assays for screening same
09/26/2001CN1314910A Adenosine derivatives
09/26/2001CN1314909A Aryl phosphate derivatives of d4T having anti-HIV activity
09/25/2001US6294659 Photocleavable nucleoside base and nucleic acids including
09/25/2001US6294522 Compounds for treatment of cardiovascular disorders
09/20/2001WO2001068867A1 Polyketides and their synthesis
09/20/2001WO2001068673A1 Oligonucleotide analogues, methods of synthesis and methods of use
09/20/2001WO2001068663A1 Nucleoside compounds and uses thereof
09/20/2001WO2001068661A2 Crystalline alkycycline derivative
09/20/2001WO2001068064A2 Use of cdp-choline for the prophylactic treatment of cerebral ischemia
09/20/2001WO2001068034A2 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions
09/20/2001CA2402319A1 Oligonucleotide analogues, methods of synthesis and methods of use
09/20/2001CA2400370A1 Nucleoside compounds and uses thereof
09/20/2001CA2400043A1 Antiviral prodrugs
09/19/2001EP1133512A2 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
09/19/2001EP1133304A2 Use of nucleotides and dinucleotides for thetreatment of vaginal dryness and vulvar pain
09/19/2001EP0594667B1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
09/19/2001CN1313861A 2-(purin-9-YL)-tetrahydrofuran-3,4-diolderivatives
09/19/2001CN1313860A 2-(purin-9-YL)-tetrahydrofuran-3,4-diol, derivatives
09/18/2001US6291670 Viricides against human immunodeficiency virus and aids (acquired immune deficiency syndrome)
09/18/2001US6291447 Inhibiting the g2 checkpoint in a cell
09/18/2001US6291184 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
09/18/2001US6291183 A plurality of oligonucleotide linker molecules are attached on a planar solid support, photoremovable groups react with terminal ends of oligonucleotides, substrates exposed to light activate binding at selected areas; peptide synthesis
09/13/2001WO2001066556A1 5-pyrimidine-containing nucleic acids and reversible ligation method by using the same
09/13/2001WO2001066118A1 4'-thio-l-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof
09/13/2001US20010021521 Crotonobetanyl-coenzyme A is prepared from crotonobetaine hydrochloride and coenzyme A, characterised in that crotonobetainyl chloride is prepared form crotonobetaine hydrochloride and subsequently transformed by coenzyme A
09/13/2001US20010021506 The functionalized silicon compound containing one or more derivatizable functional group selected from the group consisting of hydroxyl, amino, amido, carboxyl, thio, halo and sulfonate, and one or more acativated silicon group
09/12/2001EP1132393A1 L-Ribavirin and uses thereof
09/12/2001EP0629203B1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents
09/12/2001CN1312254A Novel nucleoside
09/11/2001US6288234 Fluorinated heterocyclic amido amine compounds as drugs
09/11/2001US6288221 Methods of synthesis of halogen base-modified oligonucleotides and subsequent labeling with a metal-catalyzed reaction
09/11/2001US6287821 Nucleotide having cleavable linking group, spacer linking group, and reporter molecule attached at 3' position; reporter molecule has greater fluorescence when unattached from nucleotide; sensitive amplification of signal
09/07/2001WO2001064958A2 Modified oligonucleotides for mismatch discrimination
09/07/2001WO2001064706A1 Antisense modulation of e2f transcription factor 1 expression
09/07/2001WO2001064702A1 Process for the preparation of phosphorothioate triesters
09/07/2001CA2401781A1 Modified oligonucleotides for mismatch discrimination
09/07/2001CA2401083A1 Process for the preparation of phosphorothioate triesters
09/06/2001US20010020089 Purine derivatives
09/05/2001EP1129098A2 Methods of making modified nucleosides
09/05/2001EP1109825A4 Improved process for the synthesis of oligonucleotides incorporating 2-aminoadenosine
09/05/2001EP1000075A4 Method of producing tiazofurin and other c-nucleosides
09/05/2001CN1311630A Novel nucleosides having bicycle surgar moiety
08/2001
08/30/2001WO2001062769A1 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
08/30/2001WO2001062768A1 2-thioether a2a receptor agonists
08/30/2001WO2001025248A3 Design of high affinity rnase h recruiting oligonucleotide
08/30/2001US20010018514 Nucleic acid labeling compounds
08/30/2001US20010018512 For biopolymer
08/30/2001US20010018428 C-pyrazole A2A receptor agonists
08/30/2001US20010018184 Heterogenous assay for pyrophosphate
08/29/2001EP1126828A1 Oral administration of adenosine analogs
08/29/2001EP0851866B1 Therapeutic compounds
08/29/2001EP0618925B1 Antisense oligonucleotides
08/29/2001CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
08/29/2001CN1309970A Application of uridine phosphorylase inhibitor and composition containing the same
08/28/2001US6281376 Therapeutic compound—fatty acid conjugates
1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 201